ketanserin has been researched along with Bilateral Headache in 2 studies
Ketanserin: A selective serotonin receptor antagonist with weak adrenergic receptor blocking properties. The drug is effective in lowering blood pressure in essential hypertension. It also inhibits platelet aggregation. It is well tolerated and is particularly effective in older patients.
ketanserin : A member of the class of quinazolines that is quinazoline-2,4(1H,3H)-dione which is substituted at position 3 by a 2-[4-(p-fluorobenzoyl)piperidin-1-yl]ethyl group.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Verheggen, R | 1 |
| Freudenthaler, S | 1 |
| Meyer-Dulheuer, F | 1 |
| Kaumann, AJ | 1 |
| Srikiatkhachorn, A | 1 |
| Anthony, M | 1 |
2 other studies available for ketanserin and Bilateral Headache
| Article | Year |
|---|---|
Participation of 5-HT1-like and 5-HT2A receptors in the contraction of human temporal artery by 5-hydroxytryptamine and related drugs.
Topics: Adult; Aged; Benzazepines; Collagenases; Endothelium, Vascular; Female; Headache; Humans; In Vitro T | 1996 |
Serotonin receptor adaptation in patients with analgesic-induced headache.
Topics: Adolescent; Adult; Aged; Analgesics; Blood Platelets; Female; Headache; Humans; Ketanserin; Male; Mi | 1996 |